Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydrocortisone for prevention of dexamethasone-induced neuropsychiatric adverse effects in neurosurgical brain tumor patients
2017-003705-17Phase 4Terminated
- Sponsor
- Leiden University Medical Center
- Start
- Jan 2019
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of hydrocortisone, dexamethasone in None, sleep disorder, sponsored by Leiden University Medical Center. Started Jan 2019; status: terminated.
02
Drugs
hydrocortisonedexamethasone
03
Conditions
sleep disorder
Beyond the preview
Go deeper on 2017-003705-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-003705-17.